Reprograming The Tumor Immunologic Microenvironment Using Neoadjuvant Chemotherapy In Osteosarcoma

Cancer Science
02 Jul, 2020 ,

Chuangzhong Deng conducted a study to assess Tumor‐infiltrating immune cells as they play a crucial role in tumor progression and response to treatment. The researchers concluded that application of chemotherapy may activate the local immune status and convert OS into an immune “hot” tumor.